BerandaGBM • FRA
add
Inovio Pharmaceuticals Inc
Tutup sebelumnya
€1,63
Rentang hari
€1,59 - €1,61
Rentang tahun
€1,30 - €11,94
Kapitalisasi pasar
66,01 jt USD
Volume Rata-Rata
115,00
Rasio P/E
-
Hasil dividen
-
Bursa utama
NASDAQ
Berita pasar
Keuangan
Laporan Pendapatan
Pendapatan
Laba bersih
| (USD) | Des 2024info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 116,99 rb | 13,97% |
Biaya operasional | 7,60 jt | 37,12% |
Laba bersih | -19,38 jt | 22,48% |
Margin laba bersih | -16,57 rb | 31,99% |
Penghasilan per saham | -0,60 | 89,42% |
EBITDA | -19,95 jt | 9,81% |
Tarif pajak efektif | — | — |
Neraca
Total aset
Total liabilitas
| (USD) | Des 2024info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 94,11 jt | -35,23% |
Total aset | 113,20 jt | -33,78% |
Total liabilitas | 44,69 jt | -16,62% |
Total ekuitas | 68,50 jt | — |
Saham yang beredar | 36,67 jt | — |
Harga terhadap nilai buku | 0,86 | — |
Tingkat pengembalian aset | -46,24% | — |
Tingkat pengembalian modal | -61,22% | — |
Arus Kas
Perubahan kas bersih
| (USD) | Des 2024info | Perubahan Y/Y |
|---|---|---|
Laba bersih | -19,38 jt | 22,48% |
Kas dari operasi | -19,66 jt | 25,16% |
Kas dari investasi | 34,64 jt | 73,71% |
Kas dari pembiayaan | 29,15 jt | 1.485,47% |
Perubahan kas bersih | 44,13 jt | 1.081,94% |
Arus kas bebas | 3,91 jt | 127,61% |
Tentang
Inovio Pharmaceuticals, Inc. is an American biotechnology company focused on the discovery, development, and commercialization of synthetic DNA products for treating cancers and infectious diseases. In April 2020, Inovio was among some 100 companies, academic centers, or research organizations developing a vaccine candidate for treating people infected with COVID-19, with more than 170 total vaccine candidates in development. Wikipedia
Didirikan
1999
Situs
Karyawan
134
